Determinants of vaccination uptake, and influenza vaccine effectiveness in preventing deaths and hospital admissions in the elderly population; Treviso, Italy, 2014/2015-2016/2017 seasons.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
2020
Historique:
pubmed: 6 9 2019
medline: 22 6 2021
entrez: 6 9 2019
Statut: ppublish

Résumé

Seasonal influenza is an important cause of morbidity and mortality, particularly among the elderly population. Determinants of vaccination uptake and its impact on health outcomes in the seasons 2014/2015-2016/2017 in elderly living in Treviso area (Veneto Region, North-Eastern Italy) were evaluated. A retrospective cohort study was conducted combining information from several health administrative databases, and multiple Poisson regression models were applied to evaluate the influenza vaccine effectiveness, also adjusting for confounding factors. MF59-adjuvanted trivalent-inactivated vaccine was mainly administered. Data from more than 83,000 elderly people were analyzed by year. Vaccine coverage was about 50%; influenza vaccination uptake was independently associated with older age, male sex, increasing number of underlying chronic conditions, previous pneumococcal vaccination, annual expenses for specialist medical cares, and general practitioner to whom the elderly was in charge. After adjusting for previously described characteristics, vaccination was associated with lower mortality and influenza-related hospitalization rates. Specifically, during influenza season the adjusted incidence rate ratio of death and of influenza-related hospitalizations for vaccinated compared to unvaccinated persons was 0.63 [95% confidence interval (CI) 0.58-0.69,

Identifiants

pubmed: 31486347
doi: 10.1080/21645515.2019.1661754
pmc: PMC7062427
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-312

Références

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876
pubmed: 20166072
BMC Med. 2019 Jan 10;17(1):9
pubmed: 30626399
Int J Environ Res Public Health. 2017 Jun 20;14(6):
pubmed: 28632192
Eur J Epidemiol. 2001;17(2):163-8
pubmed: 11599691
Infect Chemother. 2013 Jun;45(2):159-74
pubmed: 24265964
Epidemiol Prev. 2015 Jul-Aug;39(4):234-42
pubmed: 26499236
Influenza Other Respir Viruses. 2018 Jul;12(4):423-437
pubmed: 29125681
Hum Vaccin Immunother. 2013 Jan;9(1):144-52
pubmed: 23143775
Influenza Other Respir Viruses. 2018 Jul;12(4):533-543
pubmed: 29498477
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583
pubmed: 29109276
J Epidemiol Community Health. 2002 Dec;56(12):951-5
pubmed: 12461118
Vaccine. 2018 Sep 18;36(39):5916-5925
pubmed: 30077480
Expert Rev Vaccines. 2019 Jun;18(6):671-679
pubmed: 31159616
Am J Epidemiol. 2009 Sep 1;170(5):650-6
pubmed: 19625341
CMAJ. 2016 Oct 4;188(14):E342-E351
pubmed: 27455981
Vaccine. 2017 Nov 1;35(46):6269-6274
pubmed: 29032898
Epidemiol Prev. 2005 May-Aug;29(3-4):195-203
pubmed: 16454413
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
J Infect Dis. 2019 Aug 30;220(7):1136-1140
pubmed: 31107953
Int J Mol Sci. 2017 Jul 18;18(7):
pubmed: 28718801
Vaccine. 2018 Sep 5;36(37):5556-5564
pubmed: 30076104
Public Health. 2018 Mar;156:67-78
pubmed: 29408191
Am J Med. 2016 Jun;129(6):636.e1-636.e11
pubmed: 26551981
Epidemiol Infect. 2017 Mar;145(4):775-786
pubmed: 27927253
Euro Surveill. 2017 Jul 27;22(30):
pubmed: 28797322
Br J Math Stat Psychol. 2012 Feb;65(1):163-80
pubmed: 21950803
BMC Infect Dis. 2013 Jul 26;13:348
pubmed: 23890405
JAMA. 2004 Sep 15;292(11):1333-40
pubmed: 15367555
Ann Ist Super Sanita. 2018 Jan-Mar;54(1):67-71
pubmed: 29616677
BMJ. 2013 Aug 23;347:f5061
pubmed: 23974637
Am J Med. 2008 Apr;121(4):258-64
pubmed: 18374680
BMC Public Health. 2014 Aug 07;14:813
pubmed: 25103091
Int J Epidemiol. 2006 Apr;35(2):345-52
pubmed: 16368724

Auteurs

Stefania Bellino (S)

Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy.

Cinzia Piovesan (C)

Department of Epidemiology, Local Health Unit 2 Marca Trevigiana, Treviso, Italy.

Antonino Bella (A)

Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy.

Caterina Rizzo (C)

Direction of Clinical Departments, Bambino Gesù Children's Hospital, Rome, Italy.

Patrizio Pezzotti (P)

Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy.

Mauro Ramigni (M)

Department of Epidemiology, Local Health Unit 2 Marca Trevigiana, Treviso, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH